NCT07457697

Brief Summary

MyGENESIS-PATH is a self-guided digital psychoeducational intervention designed to support donor-conceived adults in navigating donor-conception-related information and uncertainty, DNA testing, identity, family relationships, disclosure, stigma, and expectations concerning donors and donor siblings. This two-arm randomized pilot and feasibility trial will evaluate the feasibility and acceptability of delivering MyGENESIS-PATH and of conducting a future definitive randomized controlled trial. Sixty donor-conceived adults will be randomly allocated in a 1:1 ratio to immediate access to MyGENESIS-PATH or to a waitlist control condition. Primary feasibility outcomes will assess recruitment, completion of the 4-week follow-up assessment, completeness of psychosocial outcome data, intervention uptake and completion, and completion of the immediate post-intervention feedback assessment. Intervention acceptability, usability, perceived usefulness, relevance, emotional manageability, and potential unwanted effects will be assessed among participants allocated to MyGENESIS-PATH. Changes in perceived stress, psychological well-being, coping, and donor-conception-related identity from baseline to 4 weeks after randomization will be examined as exploratory outcomes. The study is not powered to detect definitive intervention effects.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
3mo left

Started Aug 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 17, 2026

Completed
20 days until next milestone

First Posted

Study publicly available on registry

March 9, 2026

Completed
5 months until next milestone

Study Start

First participant enrolled

August 18, 2026

Expected
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 31, 2026

1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2026

Last Updated

July 17, 2026

Status Verified

July 1, 2026

Enrollment Period

2 months

First QC Date

February 17, 2026

Last Update Submit

July 15, 2026

Conditions

Keywords

donor-conceived peopledonor conceptionPsychoeducational interventionDigital interventionCognitive-behavioral trainingStress and copingPsychological well-beingRandomized controlled trial

Outcome Measures

Primary Outcomes (3)

  • Recruitment feasibility

    Number of eligible participants who provide informed consent, complete the baseline questionnaire, and are randomized during the planned recruitment period. The recruitment target is 60 randomized participants within the planned recruitment period. The number screened, number eligible, number consenting, number completing baseline, and mean number randomized per month will also be reported.

    From recruitment opening to completion of recruitment, anticipated to be approximately 3 months

  • Acceptability of MyGENESIS-PATH

    Acceptability will be assessed immediately after intervention completion among participants allocated to MyGENESIS-PATH using participant ratings of perceived usefulness; perceived relevance; emotional manageability; willingness to recommend the intervention to another donor-conceived person. Acceptability will also be explored qualitatively through optional open-ended feedback.

    Immediately after completing the intervention.

  • Completion of the 4-week follow-up assessment

    Percentage of all randomized participants who submit the 4-week follow-up questionnaire. The numerator will be the number of randomized participants submitting the follow-up questionnaire, and the denominator will be all randomized participants. A completion rate of at least 80% will support progression without major modification.

    4 weeks after randomization

Secondary Outcomes (3)

  • Psychological well-being

    Baseline (pre-intervention) and 4 weeks post-randomization

  • Coping

    Baseline (pre-intervention) and 4 weeks post-randomization

  • Donor-conception identity

    Baseline (pre-intervention) and 4 weeks post-randomization

Study Arms (2)

MyGENESIS Intervention

EXPERIMENTAL

Participants randomized to this arm receive access to the MyGENESIS digital psychoeducational program, consisting of five sequential self-guided online modules.

Behavioral: MyGENESIS Digital Psychoeducational Program

Waitlist Control Group

NO INTERVENTION

Participants in this arm do not receive access to the MyGENESIS intervention during the study period and are offered access after completion of post-test assessments.

Interventions

A self-guided digital psychoeducational intervention based on cognitive-behavioral principles and the transactional model of stress.

MyGENESIS Intervention

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Donor-conceived people
  • Aged 18 or over
  • Able to read and understand English
  • Provide informed consent

You may not qualify if:

  • Previous participation in the MyGENESIS-PATH alpha-testing phase
  • Unable to provide informed consent
  • Unable to complete the online study procedures

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Psychology and Education Sciences, University of Porto

Porto, Porto District, 4200, Portugal

Location

MeSH Terms

Conditions

Psychological Well-Being

Condition Hierarchy (Ancestors)

Personal SatisfactionBehavior

Central Study Contacts

Mariana V. Martins, PhD

CONTACT

Maria E. Costa, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
This is an open-label study. Participants will know whether they have immediate access to MyGENESIS-PATH. The research team will also have access to group allocation where required for intervention administration and follow-up. Outcomes will be assessed using self-administered online questionnaires. No blinded outcome assessor is involved.
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: This study uses a two-arm, parallel-group randomized pilot and feasibility design. After completing the baseline questionnaire, participants will be automatically randomized within the online platform in a 1:1 ratio to immediate access to MyGENESIS-PATH (IG) or to a waitlist control condition. Participants allocated to the IG will receive access to a self-guided digital psychoeducational intervention comprising six sequential modules, personalised pathways, reflective activities, brief check-ins, and tailored coping exercises. Participants allocated to the CG will not receive access during the initial 4-week study period (access after completing the 4-week follow-up assessment). IG participants will complete a brief feedback assessment immediately after reaching the end of MyGENESIS-PATH. Psychosocial outcomes will be assessed in both groups at baseline and 4 weeks after randomization. This pilot and feasibility study is not powered to detect definitive intervention effects.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

February 17, 2026

First Posted

March 9, 2026

Study Start (Estimated)

August 18, 2026

Primary Completion (Estimated)

October 31, 2026

Study Completion (Estimated)

November 30, 2026

Last Updated

July 17, 2026

Record last verified: 2026-07

Data Sharing

IPD Sharing
Will share

De-identified individual participant data and supporting documentation (study protocol, statistical analysis plan, and informed consent form template) will be made available upon reasonable request to the principal investigator following publication of the primary results. Requests will be reviewed by the research team and will require a data sharing agreement and confirmation of ethical approval where applicable.

Locations